Oragenics, Inc. (OGEN)

Oragenics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	0.04	0.13	0.09	-
Revenue Growth (YoY)	-	-71.37%	51.20%	-	-
Cost of Revenue	4.11	15.49	10.07	10.59	22.11
Gross Profit	-4.11	-15.45	-9.94	-10.5	-22.11
Selling, General & Admin	6.44	5.45	4.48	5.27	4.53
Other Operating Expenses	-	-	-	0	0
Operating Expenses	6.44	5.45	4.48	5.27	4.54
Operating Income	-10.56	-20.9	-14.42	-15.77	-26.64
Interest Expense	-0.03	-0.03	-0.02	-0.02	-0.01
Interest & Investment Income	0.05	0.21	0.14	0.08	0.09
Currency Exchange Gain (Loss)	-0.03	-	-	-	-
Other Non Operating Income (Expenses)	-	0.07	0.01	0	0
EBT Excluding Unusual Items	-10.57	-20.66	-14.29	-15.71	-26.56
Other Unusual Items	-	-	-	-	0.13
Pretax Income	-10.57	-20.66	-14.29	-15.71	-26.43
Earnings From Continuing Operations	-10.57	-20.66	-14.29	-15.71	-26.43
Net Income	-10.57	-20.66	-14.29	-15.71	-26.43
Net Income to Common	-10.57	-20.66	-14.29	-15.71	-26.43
Shares Outstanding (Basic)	7	2	2	2	1
Shares Outstanding (Diluted)	7	2	2	2	1
Shares Change (YoY)	194.35%	11.97%	3.40%	106.24%	33.69%
EPS (Basic)	-1.60	-9.18	-7.11	-8.09	-28.05
EPS (Diluted)	-1.60	-9.18	-7.11	-8.09	-28.05
Free Cash Flow	-8.6	-7.29	-15.36	-13.51	-16.95
Free Cash Flow Per Share	-1.30	-3.24	-7.64	-6.96	-17.99
Operating Margin	-	-55519.89%	-10964.61%	-18131.88%	-
Profit Margin	-	-54858.14%	-10863.96%	-18062.03%	-
Free Cash Flow Margin	-	-19363.34%	-11675.70%	-15535.76%	-
EBITDA	-10.53	-20.88	-14.38	-15.73	-26.59
D&A For EBITDA	0.03	0.03	0.04	0.04	0.05
EBIT	-10.56	-20.9	-14.42	-15.77	-26.64

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q